Friday, July 10, 2026

Patent directory · USPTO A61K / A61P

Patents matching “pimavanserin”

12 pharma patents match "pimavanserin" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 12
Index total 30,257
Page 1 / 1

Quick answer

This filtered view shows 12 pharmaceutical patents matching "pimavanserin" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

12 results for “pimavanserin” · 30,257 patents in full index Clear search

  1. US 11464768

    Pimavanserin alone or in combination for use in the treatment of Alzheimer's disease psychosis

    ACADIA Pharmaceuticals Inc. · Granted Oct 11, 2022 · Expires Oct 6, 2042

    granted
  2. US 11452721

    Formulations of pimavanserin

    ACADIA Pharmaceuticals Inc. · Granted Sep 27, 2022 · Expires Sep 22, 2042

    granted
  3. US 11191757

    Combination of pimavanserin and cytochrome P450 modulators

    ACADIA Pharmaceuticals Inc. · Granted Dec 7, 2021 · Expires Dec 2, 2041

    granted
  4. US 11135211

    Pimavanserin for treating impulse control disorder

    ACADIA Pharmaceuticals Inc. · Granted Oct 5, 2021 · Expires Sep 30, 2041

    granted
  5. US 10953000

    Combination of pimavanserin and cytochrome P450 modulators

    ACADIA Pharmaceuticals Inc. · Granted Mar 23, 2021 · Expires Mar 18, 2041

    granted
  6. US 10849891

    Formulations of pimavanserin

    ACADIA Pharmaceuticals Inc. · Granted Dec 1, 2020 · Expires Nov 26, 2040

    granted
  7. US 10646480

    Formulations of pimavanserin

    ACADIA Pharmaceuticals Inc. · Granted May 12, 2020 · Expires May 7, 2040

    granted
  8. US 10517860

    Combination of pimavanserin and cytochrome P450 modulators

    ACADIA Pharmaceuticals Inc. · Granted Dec 31, 2019 · Expires Dec 26, 2039

    granted
  9. US 10449185

    Formulations of pimavanserin

    ACADIA Pharmaceuticals Inc. · Granted Oct 22, 2019 · Expires Oct 17, 2039

    granted
  10. US 9757366

    Methods for the treatment of parkinson's disease psychosis using pimavanserin

    ACADIA Pharmaceuticals Inc. · Granted Sep 12, 2017 · Expires Sep 7, 2037

    granted
  11. US 9446037

    Methods for the treatment of parkinson's disease psychosis using pimavanserin

    ACADIA Pharmaceuticals Inc. · Granted Sep 20, 2016 · Expires Sep 15, 2036

    granted
  12. US 9050343

    Combination of pimavanserin and risperidone for the treatment of psychosis

    ACADIA Pharmaceuticals Inc. · Granted Jun 9, 2015 · Expires Jun 4, 2035

    granted